Company has now raised $6 million since founding to advance mRNA-based therapeutics designed to turn tumor cells into immune-activating cellsSAN CARLOS, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- ...

A newly published review article highlights the critical role of fatty acid metabolism in shaping the tumor microenvironment and influencing cancer progression, offering fresh perspectives for the ...

Researchers have identified how cells recognize and suppress transposons, mobile DNA elements that can destabilize genomes.

Melanoma is one of the deadliest forms of skin cancer, due in large part to its ability to rapidly develop resistance to ...

Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 ...

For most of the history, ageing has been treated as inevitable that you accept as a way of life, but that assumption has ...

Six days after Netflix dropped all eight episodes of The WONDERfools simultaneously on May 15, 2026, the South Korean ...

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.

STORM Therapeutics Ltd. (STORM), the clinical stage company targeting RNA modifications to reprogram cells and develop novel cancer therapies, today announces that a subset analysis of sarcoma ...

Jellyfish have repeatedly riddled the world of marine biology with its toughest mysteries. The immortal jellyfish might be ...

A SIMPLE urine test for lung cancer could be available for NHS use in as little as five years, scientists say. Spotting ...